Abdul Rafeh Naqash, MD
(58 Ratings)
, 32 Comments
VIEW ALL COMMENTS
About Abdul Rafeh Naqash
Abdul Rafeh Naqash, MD received his medical degree at the Government Medical College Srinagar, Kashmir. He completed Internal Medicine residency training at the University of Buffalo/Catholic Health. Subsequently, Dr. Naqash completed his sub-specialty clinical training in Hematology/Oncology at East Carolina University, Greenville, NC and a early phase clinical trial fellowship at the National Cancer Inst, Bethesda in the developmental therapeutics clinic. As part of the TSET phase 1 program at Stephenson Cancer Center, Dr. Naqash is focusing his interest in drug development and incorporating a genomically driven approach to early phase clinical trials. He is also interested in Lung Cancer, immunotherapy biomarkers , understanding resistance patters to Immunotherapy and immune toxicities. Dr. Naqash has led and collaborated extensively with national and international leaders in the field of immunotherapy. Some of this work has been published in high impact journals such as Journal of Clinical Oncology, JAMA Oncology, Journal of Immunotherapy of Cancer, Clinical Cancer Research among others. Dr. Naqash has been the recipient of several coveted nationally recognized awards, including The ASCO-SITC merit awards, The ASCO merit awards, the ASCO- Young Investigator Award and The NCI Directors Award among several others. Dr. Naqash is an executive member of the SITC Early Career Scientist Committee, the ASCO Trainee and Early Career Council, IASLC Career Development Committee where he is actively involved in working towards developing educational initiatives for early-career investigators. Dr Naqash also serves as the social media editor for JCO Precision Oncology and is a member of the ASCO Social Media Working group developing strategies to facilitate outreach for ASCO journals and ASCO meetings on social media platforms.
Outside of work, Dr. Naqash enjoys traveling, hiking and spending time with his family.
Affiliations
OU Health Stephenson Cancer Center,
OU Health Stephenson Cancer Center – Oklahoma TSET Phase I Program,
OU Health Stephenson Cancer Center – Thoracic Cancer Clinic
Awards
Consultant Editor Appreciation Award, Journal of Clinical Oncology Precision Oncology
2024
Director's Award, National Institutes of Health
2023
Oncology Educational Fellowship, AACR and the FDA Oncology Center of Excellence
2023
Impact Award, Hope Foundation for Cancer Research
2022
40 Under 40 in Cancer Award, The Association for Value-Based Cancer Care
2022
Best Oral Presentation, Oklahoma Thoracic Society
2022
Developmental Therapeutics Clinic Team Award, National Cancer Institute
2021
Allen Litchen Endowed Merit Award, Conquer Cancer Foundation
2021
Young Investigators Forum, Society of Immunotherapy of Cancer
2021
Top 5 Reviewer Award, Journal of Clinical Oncology - Precision Oncology
2021
Health Education
Board Certification
Medical Oncology
Internal Medicine
Medical School
Doctor of Medicine
Government Medical College Srinagar Kashmir
Residency
Internal Medicine
Catholic Health, University at Buffalo Buffalo, NY
Fellowship
Hematology & Oncology
East Carolina University Greenville, NC
Hematology & Oncology
National Cancer Institute Bethesda, MD
Medical Interests
Areas of Interest:
Early Phase clinical trials in solid tumors Drug development Immunotherapy biomarkers Immunotherapy resistance Immune related adverse events Lung cancer